Navigation Links
New hope for hormone resistant breast cancer
Date:7/22/2013

A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.

Seventy percent of breast cancer patients have oestrogen receptor positive cancer, and most patients respond well to anti-oestrogen therapies, for a few years at least. Within 15 years, however, 50% will relapse and eventually die from the disease.

Dr Andrew Stone, Professor Susan Clark and Professor Liz Musgrove, from Sydney's Garvan Institute of Medical Research, in collaboration with scientists from Cardiff University, have demonstrated that the BCL-2 gene becomes epigenetically 'silenced' in resistant tumours. This process is potentially detectable in the blood, providing a diagnostic marker. Their findings are now online in the international journal Molecular Cancer Therapetics.

Epigenetics involves biochemical changes in our cells that directly impact our DNA, making some genes active, while silencing others. Epigenetic events include DNA methylation, when a methyl group - one carbon atom and three hydrogen atoms - attaches to a gene, determining the extent to which it is 'switched on' or 'switched off'.

Dr Stone and colleagues have shown in human disease, as well as in several different cell models, that BCL-2 is silenced in oestrogen-resistant tumours by DNA methylation.

"The main purpose of the BCL-2 gene is to keep cells alive, so when the gene is silenced, cells become more vulnerable to chemotherapy," said Dr Stone.

"The next step will be to test our findings in clinical studies. We propose that if the BCL-2 gene is silenced, patients with oestrogen receptor positive breast cancer would benefit from combination therapy. In other words, tamoxifen could be used in combination
'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Garvan Institute of Medical Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study links cardiac hormone-related inflammatory pathway with tumor growth
2. Osteoporosis drug may help treat advanced hormone-sensitive breast cancer
3. Hormones for Digestion and Weight Loss Article and Video Published by BetterDigestion.org
4. The Gluten Free Society Launches Hormone Awareness Campaign
5. Hormone replacement therapy -- clarity at last!
6. XRMD: Beyond AREDS2: Vision Improvement using Hormones, Genetics, Methylation, Nutrition and Anti-Oxidative Therapy
7. Bioidentical Hormones Offer Natural Solution for Hormone Imbalance in Menopausal Women; Now Available at Women's Excellence in Menopause near Auburn Hills, Michigan
8. New HGH.com Web Site - Purchasing Human Growth Hormone and Bodybuilding Supplements Just Got Easier
9. Women's Excellence in Menopause Now Offering Treatment Options for Decreased Sex Drive near Rochester Hills, Michigan; Natural Therapy Available via Bioidentical Hormones
10. New Article and Video Describe How Hormones Help Lose Weight Published by BetterDigestion.org
11. Hormone Shows Potential as Diabetes Treatment in Mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... -- Polio is history in much of the world, ... Pakistan. Giving vaccinated children an extra dose of inactivated ... the highly infectious disease, a new study suggests. ... as early as a year after vaccination. Vaccinated children ... the spread of the disease, according to background information ...
(Date:7/11/2014)... new study challenges the widely held belief that light drinking ... analyzed more than 50 studies that examined drinking habits and ... that those with a form of a gene tied to ... affects how a person,s body breaks down alcohol, resulting in ... variant has been shown to lead to lower drinking over ...
(Date:7/11/2014)... is now providing worldwide clients with the most fashionable ... comes to buying summer wedding dresses online, ladies become ... of beautiful wedding gowns. Recently, the company has launched ... , The company’s current promotion is specially launched ... newest fashion trends. The top experts from AngelWeddingDress want ...
(Date:7/11/2014)... 11, 2014 American Farmer is proud ... Tuesday, July 15, 2014, at 8:30 am ET. , ... proprietary products, which are designed and formulated for use ... learn how these products help the crop realize its ... it is grown. , The show also features UniSouth ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Alliance Labs ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , In this episode, Innovations will explore ... 100mg docusate sodium in polyethylene glycol base designed to ... how the formulation functions as a hyperosmotic laxative by ...
Breaking Medicine News(10 mins):Health News:Researchers Assess New Way to Boost Polio Immunity 2Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:New Episode of American Farmer Featuring Sunbelt, UniSouth Genetics, and Michigan Milk Producers Association Airing on RFD-TV 2Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... Concentra ("Concentra" or the,"Company"), a national leader ... unique combination of medical services and general wellness ... Oregon, is known for its,safe, reliable air transportation ... was searching for an on-site health program that,matched ...
... revenues of $77.8 million, up 11% from,the prior year - Earnings per ... over the second quarter of 2007 - Operating cash flow of ... ... life,sDHA(TM), COLUMBIA, Md., Sept. 5 Martek Biosciences,Corporation (Nasdaq: MATK ...
... BOHEMIA, N.Y., Sept. 5 NBTY, Inc. (NYSE: NTY ), (http://www.NBTY.com ), a leading global manufacturer and marketer of ... follows (amounts,are rounded):, ... ... FOR THE MONTH OF AUGUST ...
... PARIS, Sept. 5 Sanofi-aventis announced the,publication of ... which,demonstrated that dronedarone (MULTAQ(TM)), a new anti-arrhythmic agent ... placebo in,maintaining sinus rhythm while not promoting pro-arrhythmias ... atrial fibrillation,(AF) and atrial flutter (AFL). AF, ...
... trauma patients, study finds , , WEDNESDAY, Sept. 5 (HealthDay ... does not reduce the need for blood transfusions among ... trauma patients. , The drug, epoetin alfa (brand ... because of potentially dangerous side effects. , "Unlike prior ...
... Club and Spa will soon have an East Valley location, ... DMB Executives, another first class Village Health Club and Spa ... Chandler,Arizona. As of July 31st, the land at the corner ... club design has been approved. The,purchase of the 7.3 acres ...
Cached Medicine News:Health News:Concentra Expands Horizon Air Employee Health Program With On-Site Clinic 2Health News:Martek Announces Third Quarter 2007 Financial Results 2Health News:Martek Announces Third Quarter 2007 Financial Results 3Health News:Martek Announces Third Quarter 2007 Financial Results 4Health News:Martek Announces Third Quarter 2007 Financial Results 5Health News:Martek Announces Third Quarter 2007 Financial Results 6Health News:Martek Announces Third Quarter 2007 Financial Results 7Health News:Martek Announces Third Quarter 2007 Financial Results 8Health News:Martek Announces Third Quarter 2007 Financial Results 9Health News:Martek Announces Third Quarter 2007 Financial Results 10Health News:Martek Announces Third Quarter 2007 Financial Results 11Health News:Martek Announces Third Quarter 2007 Financial Results 12Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 2Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 3Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 4Health News:The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia 5Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 2Health News:Controversial Anemia Drug Doesn't Cut Need for Transfusions 3Health News:Ocotillo in Chandler Will Have a Village 2
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  ... to sales of $2,202,000 for the prior year period, an ... also shown growth over the preceding quarter,s sales, continuing a ... year. Markets that experienced sales increases over the prior year ...
(Date:1/15/2014)... 2014 As health officials across the Midwest warn against ... in Michigan will offer free diagnostic ... Meijer pharmacists to administer tests and, in some cases, fill ... participating in the study. The Grand ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
Inquire...
... Designed for the elegant and ... Avenue collection includes ophthalmic and ... in a variety of shapes ... many face shapes and complexions. ...
... updated styling through the use of innovative ... collection is for the value driven consumer ... Eyewear Collection , The futuristic quality ... of the "strongest and lightest metal on ...
Inquire...
Medicine Products: